http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
NovaBay Pharmaceuticals to Hold Second Quarter 2021 Conference Call on August 12
-
NovaBay Pharmaceuticals to Participate in Two July Investment Conferences
-
NovaBay Pharmaceuticals Launches First of Several New Products to Expand Avenova Line
-
NovaBay Pharmaceuticals Reports First Quarter 2021 Financial Results
-
NovaBay Pharmaceuticals to Hold First Quarter 2021 Conference Call on May 6
-
NovaBay Pharmaceuticals’ Avenova® Warm Eye Compress for the Relief of Symptoms Associated with Dry Eye is Now Available on Amazon.com and Avenova.com
-
NovaBay Pharmaceuticals Reports 2020 Fourth Quarter and Full Year Financial Results
-
NovaBay Pharmaceuticals to Hold 2020 Fourth Quarter and Full Year Conference Call on March 25
-
NovaBay Pharmaceuticals to Participate in Virtual 33rd Annual Roth Conference
-
NovaBay Pharma (NBY) CEO Issues Letter to Stockholders
-
NovaBay CEO Issues Letter to Stockholders
-
NovaBay Pharma (NBY) Says Hypochlorous Acid Solution is Now Included in EPA N Listing of Products That Kill SARS-CoV-2
-
NovaBay Pharmaceuticals Now Included in EPA N Listing of Products That Kill SARS-CoV-2
-
NovaBay Pharmaceuticals Expands Avenova’s Geographic Reach to Australia with New Exclusive Distribution Agreement
-
NovaBay Pharmaceuticals Reports Third Quarter 2020 Financial Results
-
NovaBay Announces Consumer Launch of CelleRx® Clinical Reset™
-
NovaBay Pharma (NBY) receives FDA warning letter related to unapproved and misbranded products related to coronavirus
-
NovaBay Pharmaceuticals to Hold Third Quarter 2020 Conference Call on November 12
-
NovaBay Pharma (NBY) Regains Compliance with NYSE American Listing Standards
-
NovaBay Pharmaceuticals Regains Compliance with NYSE American Listing Standards
-
NovaBay Pharmaceuticals Expands Avenova® Consumer Marketing through Affiliate Programs and Enhanced Lifestyle Public Relations
-
NovaBay Announces that Avenova is Now Available with “Subscribe & Save”
-
NovaBay Pharma (NBY) Announces President & CEO Justin Hall to Board
-
NovaBay Appoints CEO Justin Hall to its Board of Directors
-
NovaBay Expands Avenova’s Online Distribution
-
NovaBay Pharmaceuticals Reports Second Quarter 2020 Financial Results
-
NovaBay Pharmaceuticals to Hold Second Quarter 2020 Conference Call on August 6
-
NovaBay Pharma (NBY) Reports Testing Results from Independent Third-Party Lab Confirms Avenova Kills SARS-CoV-2 (COVID-19 Virus)
-
NovaBay Pharmaceuticals Announces Laboratory Results Confirm Avenova Kills SARS-CoV-2 (COVID-19 Virus)
-
NovaBay Pharma (NBY) Issues Letter to Stockholders
-
NovaBay Pharmaceuticals Issues Letter to Stockholders
-
NovaBay Pharmaceuticals Reports First Quarter 2020 Financial Results
-
CORRECTING and REPLACING NovaBay Pharmaceuticals Appoints Andrew D. Jones Chief Financial Officer
-
NovaBay Pharmaceuticals Appoints Andrew D. Jones Chief Financial Officer
-
NovaBay Pharmaceuticals to Hold First Quarter 2020 Conference Call on May 7, 2020
-
NovaBay Pharmaceuticals Signs Agreement to Distribute COVID-19 Antibody Rapid Point-of-Care Test to U.S. Healthcare Professionals
-
NovaBay Pharmaceuticals Reports 2019 Fourth Quarter and Full Year Financial Results
-
NovaBay Pharmaceuticals Announces the Availability of KN95 Disposable Masks on Avenova.com
-
NovaBay Pharmaceuticals Unveils Refreshed Consumer Branding for Online Sales of Avenova® Antimicrobial Lid & Lash Solution
-
NovaBay Pharmaceuticals to Hold 2019 Fourth Quarter and Full Year Conference Call on March 26, 2020
-
NovaBay Pharma (NBY) Gains After Launching Eyelid Wipes on Amazon
-
NovaBay Pharmaceuticals Launches NovaWipes Eyelid Wipes on Amazon.com
-
NovaBay Pharmaceuticals Launches NovaSight™ Daily Vitamin for Ocular Health on Amazon.com
-
NovaBay Pharmaceuticals Reports 2019 Third Quarter Financial Results
-
NovaBay Pharmaceuticals Launches Online Sales of CelleRx® Skin Cleanser for Post-Aesthetic Dermatology and Cosmetic Surgery Procedures
-
NovaBay Pharmaceuticals to Hold Third Quarter 2019 Conference Call on November 7, 2019
-
NovaBay Pharmaceuticals to Distribute the NuLids System® for the Treatment of Dry Eye in Certain U.S. Geographies
-
NovaBay Pharma (NBY) Receives Approval for Distribution of Avenova in Australia
-
NovaBay Pharmaceuticals Receives Approval for Distribution of Avenova in Australia
-
NovaBay Pharma (NBY) Appoints Jeff Zheng to Board

